4D Molecular Therapeutics, a late-stage biotech company, announced its management will participate in several investor conferences from November to December 2026, including Guggenheim, Stifel, Jefferies, Evercore, Citi, Piper Sandler, and Barclays events. The company is advancing treatments for retinal diseases and cystic fibrosis, with lead candidates in late-stage development. These presentations aim to update investors on clinical progress and commercial plans, with webcasts available for a year on their website.
4D Molecular Therapeutics' upcoming investor conferences provide context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: Among 150 priced US health stocks, 75 rose and 69 fell. AHCO gained 9.81% to USD 6.49 with a typical hold time of 21 days and a strong buy bias (90% buy orders). RVTY rose 8.80% to USD 165.00 with a shorter hold time of 13 days, while NBIX increased 6.66% to USD 155.03 despite 100% sell order activity and a longer hold time of 28 days.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
